Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research
NCT02693496 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2018-08-07
Summary
Patients with lung nodules may develop a variety of potentially severe symptoms. These symptoms may impact a patient's quality of life and lead to difficult treatment. Through this research program, the investigators want to understand the pathogenesis of the changes of these symptoms.
Conditions
- Solitary Pulmonary Nodule
Interventions
- OTHER
-
Installation or registration of smartphone application
Completed the installation and registration of mobile terminal software online
Sponsors & Collaborators
-
Chinese Alliance Against Lung Cancer
lead OTHER
Principal Investigators
-
Chunxue Bai, M.D, Ph.D · Chinese Alliance Against Lung Cancer
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2025-10-31
- Completion
- 2025-10-31
Countries
- China
Study Locations
More Related Trials
-
Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary Nodules
NCT03651986 ·Status: UNKNOWN
-
Evaluation of Lung Nodule Detection With Artificial Intelligence Assisted Computed Tomography in North China
NCT03487952 ·Status: UNKNOWN
-
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
NCT05426720 ·Status: RECRUITING
-
Deep Learning Model for Pure Solid Nodules Classification
NCT05542992 ·Status: UNKNOWN
-
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
NCT06518655 ·Status: RECRUITING
-
Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules
NCT03181490 ·Status: COMPLETED
-
Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
NCT03685669 ·Status: UNKNOWN
-
Localization for Deep Lung Nodules: Microcoil Versus Contrast Injection
NCT03617029 ·Status: UNKNOWN ·Phase: NA
-
Validation of Soluble Programmed Death-1 in Predicting Progression of Nodular-bronchiectatic Form of Nontuberculous Mycobacterial Lung Disease: a Multi-Country Research
NCT05678166 ·Status: UNKNOWN
-
Breath Combined With CT for Diagnoses of Pulmonary Nodules
NCT04948047 ·Status: UNKNOWN
-
Radiomics Multifactorial Biomarker for Pulmonary Nodules
NCT03872362 ·Status: COMPLETED
-
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134 ·Status: UNKNOWN
-
Precision Diagnosis and Therapy for Early Stage Lung Cancer
NCT02936804 ·Status: UNKNOWN ·Phase: NA
-
Robotic-Assisted Navigation for Lung Nodule Localization: A Non-Inferiority Study
NCT07055997 ·Status: COMPLETED ·Phase: NA
-
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
NCT06358222 ·Status: RECRUITING
-
PD-L1 Expression in Lung Cancer
NCT04992715 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Effectiveness of Disposable Pulmonary Surgical Markers in the Localization of Pulmonary Nodules
NCT04139408 ·Status: COMPLETED ·Phase: NA
-
Real-Time Non-Invasive Localization for Multiple Lung Nodules
NCT07257549 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Robotic-assisted Bronchoscopy Combined With the ICNVA Strategy in Biopsy of Peripheral Pulmonary Nodules
NCT07136961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
NCT02971176 ·Status: COMPLETED ·Phase: NA
-
Supportive Care Mobile Application for Patients With NSCLC
NCT04629300 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules
NCT06458673 ·Status: NOT_YET_RECRUITING
-
Radiofrequency Ablation of Malignant Pulmonary Nodules
NCT02629978 ·Status: UNKNOWN ·Phase: NA
-
Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung Resection
NCT05162235 ·Status: UNKNOWN ·Phase: NA
-
irAE Prediction of Anti-PD-1/L1 in Lung Cancer
NCT05288569 ·Status: UNKNOWN